Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-028888
Filing Date
2025-06-02
Accepted
2025-06-02 19:17:24
Documents
3
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748906238.html 4  
1 FORM 4 wk-form4_1748906238.xml 4 5520
2 EX-24 bischofberger-form144and.htm EX-24 3081
3 bischofberger-form144and001.jpg GRAPHIC 191395
  Complete submission text file 0001628280-25-028888.txt   273791
Mailing Address 333 LAKESIDE DR C/O GILEAD SCIENCES, INC. FOSTER CITY CA 94404
Business Address
BISCHOFBERGER NORBERT W (Reporting) CIK: 0001190273 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 251016733

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)